Clinical Trial Update: A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating TNX-102 SL for fibromyalgia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• TNX-102 SL (cyclobenzaprine hydrochloride)

Snippet

Sponsor: Tonix Pharmaceuticals, Inc. | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2022-12-02